Atlas Trials

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

Clinical trial NCT00314288 · COMPLETED

Trial details

NCT number
NCT00314288
Sponsor
EMD Serono
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's DiseaseDyskinesia
Start date
2002-07-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.